Boston Scientific Corpora... (BSX)
NYSE: BSX
· Real-Time Price · USD
104.16
1.66 (1.62%)
At close: Aug 14, 2025, 3:59 PM
104.10
-0.06%
Pre-market: Aug 15, 2025, 04:01 AM EDT
Boston Scientific Fail-to-Deliver
Total FTD Shares
114
Below Average
FTD / Avg. Volume
< 0.01%
Low Impact
1-Year Change
-98.5%
Negative Trend
FTD Chart
As of Jul 14, 2025,
Boston Scientific Corporation has
114
shares failed to deliver, representing 0.00%
of the average daily volume of
7,451,374
shares. Over the past year, the monthly average FTD is
17,952
shares, with the current level 99% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.
FTD History
Date | Price | FTD Shares | % Change |
---|---|---|---|
Jul 14, 2025 | 104.33 | 114 | -90.80% |
Jun 30, 2025 | 107.41 | 1.24K | +376.54% |
May 29, 2025 | 104.5 | 260 | -95.52% |
Apr 30, 2025 | 102.87 | 5.8K | +867.17% |
Mar 24, 2025 | 102.67 | 600 | -93.48% |
Feb 26, 2025 | 101.56 | 9.21K | +465.32% |
Jan 30, 2025 | 103.04 | 1.63K | -52.06% |
Dec 31, 2024 | 89.32 | 3.4K | -98.44% |
Nov 14, 2024 | 87.59 | 217.7K | +8597.52% |
Oct 21, 2024 | 88.05 | 2.5K | +8243.33% |
Sep 30, 2024 | 83.8 | 30 | -97.77% |
Aug 26, 2024 | 79.47 | 1.34K | +134400.00% |
Jul 31, 2024 | 73.88 | 1 | -99.98% |
Jun 28, 2024 | 77.01 | 4.38K | +315.87% |
May 29, 2024 | 74.98 | 1.05K | +545.40% |
Apr 23, 2024 | 68.99 | 163 | +526.92% |
Mar 27, 2024 | 68.62 | 26 | +225.00% |
Feb 28, 2024 | 66.99 | 8 | -90.70% |
Jan 30, 2024 | 61.42 | 86 | -94.16% |
Dec 28, 2023 | 56.28 | 1.47K | -93.91% |
Nov 30, 2023 | 55.89 | 24.18K | +72.61% |
Oct 27, 2023 | 49.52 | 14.01K | +31033.33% |
Sep 22, 2023 | 53.6 | 45 | -97.47% |
Aug 03, 2023 | 50.88 | 1.78K | -75.18% |
Jul 27, 2023 | 52.64 | 7.17K | +1351.82% |
Jun 30, 2023 | 54.09 | 494 | +112.93% |
May 25, 2023 | 51.54 | 232 | -86.17% |
Apr 27, 2023 | 52.03 | 1.68K | -87.26% |
Mar 30, 2023 | 49.6 | 13.17K | +8921.92% |
Feb 23, 2023 | 47.18 | 146 | -74.48% |
Jan 31, 2023 | 46.25 | 572 | n/a |